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Abstract
Background: Although echocardiography is commonly used to evaluate cardiac function after MI, CMR
may provide more accurate functional assessment but has not been adequately compared with echo. The
primary study objective was to compare metrics of left ventricular volumes and global and regional
function determined by cardiac magnetic resonance (CMR) and echocardiography (echo) in patients (pts)
with recent myocardial infarction (MI).
Methods: To compare CMR with echo, 47 consecutive patients (pts 70% male; mean age = 66 ± 11 years)
with MI >6 wks previously and scheduled for imaging evaluation were studied by both echo and CMR
within 60 min of each other. Readers were blinded to pt information. Pearson's correlation coefficient,
paired t-tests, and chi-square tests were used to compare CMR and echo measures. Further comparisons
were made between pts and 30 normal controls for CMR and between pts and published normal ranges
for echo.
Results: Measures of volume and function correlated moderately well between CMR and echo (r = 0.54
to 0.75, all p < 0.001), but large and systematic differences were noted in absolute measurements. Echo
underestimated left ventricular (LV) volumes (by 69 ml for end-diastolic, 35 ml for end-systolic volume,
both p < 0.001), stroke volume (by 34 ml, p < 0.001), and LV ejection fraction (LVEF) (by 4 percentage
point, p = 0.02). CMR was much more sensitive to detection of segmental wall motion abnormalities (p <
0.001). CMR comparisons with normal controls confirmed an increase in LV volumes, a decrease in LVEF,
and preservation of stroke volume after MI.
Conclusion: This intra subject comparison after MI found large, systematic differences between CMR and
echo measures of volumes, LVEF, and wall motion abnormality despite moderate inter-modality
correlations, with echo underestimating each metric. CMR also provided superior detection and
quantification of segmental function after MI. Serial studies of LV function in individual patients should use
the same modality.
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Background
Cardiac magnetic resonance (CMR) is increasingly uti-
lized for dynamic imaging of the heart with the expecta-
tion that it will provide more accurate and reproducible
measurements of cardiac chamber dimensions, volumes,
and function compared to other non-invasive imaging
techniques such as echocardiography and nuclear cardi-
ography [1-3]. This expectation arises from the superior
spatial resolution and more precise border definition
achieved with CMR compared with these other tech-
niques. However, the potential of CMR to be integrated
optimally into clinical practice for assessment of cardiac
metrics has been limited in part by a lack of comparative
information with echocardiography (echo), the long-time
clinical standard for non-invasive cardiovascular imaging,
in health and disease. Myocardial infarction (MI) is the
most common cardiovascular disease state routinely
requiring imaging assessment. Little direct comparative
information is available for these 2 techniques [4]. Thus,
we undertook an intra subject comparison of echo with
CMR in a consecutive cohort of post-MI patients to deter-
mine correlations and systematic differences between




The main study objectives were: 1) to determine and com-
pare metrics of left ventricular volumes and function
between CMR and echo in a consecutive cohort of post-MI
patients presenting for imaging evaluation of cardiac
function, 2) to compare the sensitivity of the 2 modalities
to assess regional wall motion (RWM) after MI, and 3) to
quantitatively assess changes in these parameters after MI
by a comparison of study patients with a cohort of normal
volunteers.
Study Population
Forty-seven study subjects were prospectively enrolled
from a consecutive series of patients with MI occurring >6
wks previously referred for echo evaluation of cardiac
function and who consented to study participation, which
included undergoing the complementary CMR study
within 1 hour of echo. The protocol was approved by the
Western Institutional Review Board. Standard electrocar-
diogram (ECG) and serial cardiac biomarker analysis was
used to document MI.
Each subject served as his/her own control. Predefined
cardiovascular measurements were made for CMR and
echo using workstation-specific methods by a seasoned
observer blinded to results of the complementary imaging
method. Imaging results and demographic information
were entered into a study database.
Given limited information on the normal range for CMR
measurements and dependence of work-station specific
methodology, we determined a normal range for CMR
metrics in a group of 30 local normal volunteers recruited
concurrently [5]. These subjects were consenting, uncom-
pensated adults of either sex (equally divided between
men and women) of ages between 40–60 years who
underwent a standard CMR functional study and who had
no clinically apparent cardiovascular diseases, including
hypertension or diabetes on screening history, or abnor-
mal physical on screening examination, or significant
other-organ diseases. Echocardiographic normal values
were taken from the published literature.
Cardiac Magnetic Resonance Imaging (MRI) and Echo 
Studies
Following axial and sagittal localizer sequences, standard
cardiac 2, 3, and 4 chamber 1 cm thick long axis and short
axis slices were obtained on a General Electric (GE) 1.5
Tesla magnet (EXCITE platform, version 11.0) using
steady state free precession (SSFP) cine sequences (typical
in-plane resolution 2.2 × 1.3 mm2). All images were
acquired using a phased-array 8-channel cardiac coil dur-
ing single breath-holds (maximum, 15 seconds) with
ECG (preferred) or peripheral (finger pulse) triggering.
Acquisition parameters were as follows: zoom mode, TR =
2.4 msec, TE = min full, flip angle = 45°, field of view = 35
× 35 cm, matrix = 192 × 160, NEX = 0.5, slice thickness =
8 mm with zero spacing, phases = 20, and views per seg-
ment ≤ 24 to maintain temporal resolution < 80 msec. No
vasoactive agents were given between echocardiography
and CMR imaging.
Echocardiographic images were obtained in the standard
parasternal long and short axis and apical 4 chamber and
2 chamber views utilizing digital Vivid 7 ultrasound
equipment with a combined tissue imaging 2.5 – 4.0 MHz
transducer (GE, Milwaukee, WI). At least 3 cardiac cycles
were captured at the left ventricular (LV) base, mid papil-
lary muscle level, and apex for wall motion assessment.
No intravenous echocardiographic contrast agent was
used. Later, an expert reader obtained measurements off-
line from the parasternal and apical windows blinded to
patient identity, gender, and clinical data. Two dimen-
sional (2D) echo ventricular volumes and LV ejection
fraction were planimetered from the 4-chamber and 2-
chamber areas using the modified Simpson's rule. All of
the measurements were obtained in concordance with
American Society of Echocardiography standards [6].
Image Analysis
Off-line image post-processing was performed on a car-
diac Delta workstation with ReportCard 2.0 software (GE,
Waukesha, WI). Measurements followed standard CMRCardiovascular Ultrasound 2009, 7:38 http://www.cardiovascularultrasound.com/content/7/1/38
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procedures or mimicked the approach to echo measure-
ment where appropriate. Image grayscale was adjusted to
maximize the myocardial blood pool contrast without
maximal pixel intensity saturation. Manual planimetry
was performed by an expert CMR technologist and inde-
pendently confirmed by the CMR physician reader.
(Observers were blinded to echo results.) In the short axis
view, the most basal slice used for LV volume analysis
excluded any LV outflow tract. Unattached papillary mus-
cles were included within the left ventricular chamber.
Volumes for CMR were determined from the stack of short
axis slices using Simpson's rule and for echo using the
modified, semi-Simpson's rule based on 4- and 2-cham-
ber planimetry [1,7,8]. For both modalities, floating pap-
illary muscles were included within the chamber volume
measurements. For both modalities, wall segments were
divided by consensus into 2 general categories: good/ade-
quate and suboptimal/poor. To provide a conservative
comparison of the 2 modalilties, poorly imaged segments
were excluded from the comparative analyses.
Consensus quantitative results were entered prospectively
into research databases, and computer-assisted manual
tracings were saved for later visual comparisons. Similarly,
echo image analysis was performed by experienced
observers blinded to CMR study results and followed
standard techniques [7-9].
Segmental wall motion analysis used a standard 17-seg-
ment model [10].
Study Variables
Study demographic variables included subject age, sex,
heart rate, weight, height, and body surface area (BSA).
Cardiovascular variables included LV end-diastolic (EDV)
and end-systolic (ESV) volumes and the derived variables
stroke volume (SV, SV = EDV-ESV), and LV ejection frac-
tion (EF = SV/EDV). For RWM, the LV was divided into 17
segments [11], and each visualized segment was graded
on a scale of 1 to 5 as normal, hypokinetic, akinetic, or
dyskinetic, or aneurysmal, respectively. Wall motion then
was assessed as a summed total score, a worst segmental
score, and an average RWM score, calculated as the aver-
age of all scored segments [7].
Statistics
Results are presented as mean (standard deviation). Pear-
son's correlation coefficient, paired t-tests, and chi-square
tests were used to compare intra subject and inter modal-
ity CMR and echo metrics, as appropriate. SPSS for Win-
dows (version 14.0, SPSS Inc., Chicago, IL) was used for
statistical analysis. A p value of 0.05 or less was deemed
nominally significant and 0.01 or less definitely signifi-
cant, given the 5 primary outcome variables.
Results
Subject Characteristics
50 patients were initially enrolled. Three patients were
excluded from study due to a rhythm other than sinus.
Thus, the primary study population included 47 patients
surviving MI that occurred at least 6 weeks previously.
Demographics and selected patient characteristics are
shown in Table 1. Mean age averaged 66 ± 11 years; 70%
of subjects were male.
The CMR control group included 30 healthy volunteers
(15 women, 15 men) of average age 47 years (range, 40 to
60) with average BSA 1.7 sq m in women and 2.1 sq m in
men. Study quality was excellent for all volunteers.
CMR and Echo Volumetrics
The volumetric measures of LVEDV, LVESV, and LVSV cor-
related moderately well between CMR and echo (r = 0.54
to 0.75, all p < 0.001), but large and systematic differences
were noted in absolute measurements between the two
(Table 2, Figure 1). Echo underestimated all 3 volumes:
LVEDV by an average of 69 ml, LVESV by 35 ml, and
stroke volume by 34 ml (Table 2).
Global and Segmental Function by CMR and Echo
Global LV ejection fraction correlated moderately well
between the 2 modalities (r = 0.67, p < 0.001) (Table 2).
However, echo underestimated LVEF compared to CMR
by 4 percentage points (p = 0.02).
All 799 segments in all 47 study patients could be scored
by CMR, whereas 22 (2.8%) segments (p < 0.0001) in 9
patients (19%)(p = 0.005) could not be adequately visu-
alized to allow scoring by echo and are excluded from the
comparative wall motion analyses with CMR.
In keeping with global function, segmental wall motion
scores (WMS) showed moderately good correlations
Table 1: Baseline Characteristics of the Post-MI Patient Cohort
Metric (unit) Frequency/Descriptive
N4 7
Age: y, mean (SD) 66 (11)
Sex: % (n) male 70 (33)
Heart rate: beats/min, mean (SD) 64 (14)
Body surface area: m2, mean (SD) 1.96 (0.23)
Location of WMA10 *:
Anterior/Anteroseptal†, % (n) 62 (29)
Inferior†, % (n) 77 (36)
Lateral†, % (n) 45 (21)
Apical†, % (n) 68 (32)
None†, % (n) 4 (2)
*Wall motion abnormality (WMA) assessed by CMR using the 
standard 17 segment model with assigned coronary territories10†Cardiovascular Ultrasound 2009, 7:38 http://www.cardiovascularultrasound.com/content/7/1/38
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between CMR and echo, both for the worst WMS (r =
0.69, p < 0.001) and for total and average segmental WMS
(r = 0.66, p = 0.001)(Table 2). However, echo underesti-
mated WMS of the worst segment (by 0.81 grade, p <
0.001), as well as the average WMS and the summed WMS
compared to CMR (both p < 0.001)(Table 2). Wall
motion was completely normal in 15 patients (32%)
assessed by echo, compared to only 2 (4%) assessed by
CMR (p < 0.001), suggesting that CMR is more sensitive
in distinguishing diseased from normal subjects.
Subgroup Analysis by Degree of LV Dysfunction
To see whether differences in metrics by modality are
affected by degree of LV dysfunction, comparisons were
made between subgroups of patients with less than versus
more than or equal to the median echo LVEF of 46%. For
both modalities, LVEDV and LVESV increased in the lower
LVEF subgroup, whereas LVSV was unchanged. However,
inter modality differences in paired CMR versus echo
LVEF and volumetrics were not significantly dependent
on LVEF subgroup (i.e., mean ΔLVEF, 1.4% vs. 4.8%, p =
0.2; mean ΔLVEDV 58 ml vs. 77 ml, p = 0.15; high vs. low
LVEF subgroups, respectively).
Post-MI Patients and Normals Compared by CMR
Table 3 compares the primary volumetric and functional
metrics, determined by CMR, between the post-MI patient
cohort and normal volunteers, indexed to BSA. Stroke vol-
ume is preserved but is associated with moderate
decreases in LVEF accompanied by moderate to large
increases in LVEDVI and LVESVI
Post-MI Patients and Normals Compared by Echo
Table 4 compares the primary volumetric and functional
metrics, determined by echo, between the post-MI patient
cohort and a report of normal values. LVEF is moderately
decreased compared to normals. LVEDV and LVESV differ-
ences from normal values are modest and overlapping.
Indirect Comparison of Normal Ranges for CMR vs. Echo
As with the intra subject comparisons of CMR and echo in
post-MI patients, an indirect comparison of the normal
ranges for volunteers in our study and with a published
normal range for echocardiographic metrics also suggests
important differences in volumes (Table 3 vs. 4) [12].
Discussion
Study Overview
We performed a moderately large comparative CMR and
echo imaging study of post-MI patients in which each sub-
ject served as his or her own control. We found that met-
rics of LV volumes and function, acquired from near
simultaneous studies, while correlating moderately well,
showed large and systematic inter-modality differences.
Echo underestimated all primary measures compared
with CMR, including LVEDV, LVESV, SV, LVEF, and,
importantly, RWM abnormality. CMR also was more sen-
sitive in distinguishing diseased from normal subjects. Of
LV Volumes (Indexed to BSA) and Function by CMR versus  Echo Figure 1
LV Volumes (Indexed to BSA) and Function by CMR 
versus Echo. Abbreviations: CMR = cardiac magnetic reso-
nance; echo = echocardiography. Left ventricular end diasto-
lic volume index (LVEDVI), left ventricular end systolic 
volume index LVESVI), left ventricular stroke volume index 
(LVSVI), left ventricular ejection fraction (LVEF). Volumes are 
indexed to body surface area (BSA). Bars represent means, 
given with standard error whiskers. Comparisons of LVEDVI, 
LVESVI, and LVSVI between CMR and echo are significant at 
p < 0.001, and LVEF at p = 0.02.
Table 2: Summary of LV Volumes and Function by CMR versus Echo in the Post-MI cohort: Means (SD)
Metric (unit) CMR Echo p-value Correlation(r) p-value
LV EDV (ml) 171 (62) 102 (42) <0.001 0.701 <0.001
LV ESV (ml) 88 (47) 53 (28) <0.001 0.746 <0.001
LV SV (ml) 83 (24) 49 (22) <0.001 0.536 <0.001
LV EF (%) 51 (11) 47 (11) 0.02 0.672 <0.001
Worst WMS (units) 2.79 (0.88) 1.98 (0.85) <0.001 0.692 <0.001
Total WMS/pt 26.0 (7.0) 23.0 (7.0) 0.001 0.657 <0.001
Average WMS 1.53 (0.41) 1.39 (0.42) 0.001 0.657 <0.001
Abbreviations: CMR = cardiac magnetic resonance; echo = echocardiography; MI = myocardial infarction. Left ventricular end diastolic volume 
(LVEDV), left ventricular end systolic volume (LVESV), left ventricular stroke volume (LVSV), left ventricular ejection fraction (LVEF), 17 segment 
wall motion score (WMS)Cardiovascular Ultrasound 2009, 7:38 http://www.cardiovascularultrasound.com/content/7/1/38
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clinical importance, these differences by modality suggest
that serial measurements of function should be per-
formed using the same method, as large and spurious dif-
ferences may be seen if modalities are switched. Finally,
given its more accurate and reproducible determination of
function, CMR should be preferred when small to moder-
ate serial changes in these functional parameters are of
clinical importance to disease management.
Previous Work and Study Rationale
Echocardiography is a mature imaging modality [13,14]
with an accepted if not extensively studied normal range
for ventricular volumes [7,12,15,16]. Normal values for
contemporary CMR also are now published [5,17-20].
Indirect and direct comparisons of these studies suggest
that echocardiographic normal values may not accurately
reflect the normal range for ventricular [4,7,19] or atrial
[21] chamber measurements by CMR. A study in which
each imaging modality is tested (near) simultaneously
within the same subjects, and which uses carefully stand-
ardized techniques and blinded assessment, represents
the most accurate and informative design to compare
imaging modalities. Because coronary artery disease rep-
resents the most common reason for applying these imag-
ing tests, we chose a typical post-MI population for a
direct, intra subject comparative study of these 2 modali-
ties.
Maciera and Royal Brompton Hospital (London) collabo-
rators have reported on normalized left ventricular systo-
lic and diastolic function by CMR in a moderately large
study sample (n = 120) using contemporary scanner (1.5
T) and sequence (SSFP) techniques [17]. CMR analysis
used a computer-based technology with blood pool
thresholding to delineate the papillary muscles, which
were excluded from chamber volume and included in
mass measurements. As might be expected, mass measure-
ments by this method were larger and volume measure-
ments smaller than results obtained with the operator-
interactive inclusion method used here, emphasizing the
need for method-specific normal values. Alfakih also has
reported normal ranges for CMR using SSFP sequences
[18], but some of the same issues limit the comparison of
their results with the normal values derived for the present
study [5].
Normal values for cardiovascular function by MRI also
were recently assessed in 800 adult participants, equally
representing 4 ethnic groups, both sexes, and 4 age dec-
ades, in the multi-ethnic study of atherosclerosis [19]. As
in our study, papillary muscles were included in LV vol-
ume and were excluded from LV mass calculations.
Results were generally similarly to those in our popula-
tion reported here for LV volumes and ejection fraction.
Little previous information is available directly compar-
ing these two modalities in coronary artery disease.
Jenkins et-al published a comparative study in 50 patients
with previous MI [4]. Patients with poor echo images were
excluded. Correlations of MRI versus echo for LVEDV,
LVESV, and LVEF were generally similar (i.e., r = 0.61 to
0.81, p < 0.01) to those we observed (Table 2). LV vol-
umes were slightly larger and LVEF lower in their report,
indicating a somewhat sicker population. Also consistent
with our observations, volumes and LVEF were under esti-
mated by two-dimensional echo. Their study also assessed
incremental change after MI over a 1-year interval, but,
unlike our study, it did not assess or compare regional
wall motion between modalities.
Explanatory Mechanisms
This study did not directly determine the reasons for
underestimations of volumes by echo compared with
CMR. However, lower spatial (and temporal) resolution
of echo, especially at far field, together with suboptimal
acoustic windows in some patients with less complete vis-
ualization of wall segments, and greater "blooming" of
lumen/wall boundaries with echo are disadvantages rela-
tive to CMR and likely contributors to observed differ-
ences.
Table 3: Comparison of Metrics in Post-MI versus Normal 
Subjects by CMR Indexed to Body Surface Area*: Means (SD)
Metric (unit) Post-MI (N = 47) Normals (N = 30) p-value
LV EDVI* (ml/m2) 86 (28) 68 (10) 0.004
LV ESVI* (ml/m2) 44 (22) 25 (7.0) <0.001
LV SVI* (ml/m2) 41 (11) 42 (5.0) 0.72
LV EF (%) 51 (11) 65 (6.0) <0.001
*ANOVA adjusted for sex.
Abbreviations: CMR = cardiac magnetic resonance. MI = 
myocardial infarction. Left ventricular end diastolic volume index 
(LVEDVI), left ventricular end systolic volume index (LVESVI), left 
ventricular stroke volume index (LVSVI), left ventricular ejection 
fraction (LVEF)
Table 4: Comparison of Metrics in Post-MI Patients versus 
Normal Subjects by Echo Indexed to Body Surface Area*: Means 
(SD)
Metric (unit) Post-MI (N = 47) Normals12*
LV EDVI* (ml/m2) 51 (19) 54.5 (9)
LV ESVI* (ml/m2) 27 (13) 22 (5)
LV SVI* (ml/m2) 25 (12) 22.5†
LV EF (%) 47 (11) 60 (6)
†Derived estimate
Abbreviations: MI = myocardial infarction. Echo = 
echocardiography. Left ventricular end diastolic volume index 
(LVEDVI), left ventricular end systolic volume index (LVSVI), left 
ventricular stroke volume index (LVESVI), left ventricular ejection 
fraction (LVEF)Cardiovascular Ultrasound 2009, 7:38 http://www.cardiovascularultrasound.com/content/7/1/38
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Clinical Implications
Quantitative measurements of cardiovascular anatomy
and function are only of use if they are accurate and repro-
ducible and if they can be compared with a normal,
expected range of values. Incorrect interpretations, based
on an incorrect comparative range of normal, large re-test
variability, or spurious differences on serial testing with
mixed modalities can lead to inappropriate disease assess-
ment and management. Thus, the positive impact on clin-
ical practice of accurate, reproducible measures of LV
volumes and segmental and global function cannot be
over emphasized. Despite these advantages of CMR,
echocardiography has been well demonstrated by large
and multicenter studies to be effective in evaluating and
stratifying patients after MI with LV dysfunction. The clin-
ical database for CMR, although considered a gold stand-
ard, is still substantially smaller. The choice of an imaging
option should take cost as well as technical comparisons
into account to achieve an optimal cost-effectiveness
result. CMR is a moderately more expensive modality: our
current Medicare facility/professional reimbursement
rates for non-contrast studies are USD $679/121 (CMR)
versus $412/70 (echo), with full price charges often signif-
icantly higher. Beyond this, CMR requires moderately
increased acquisition and analysis times and greater
equipment and facility expenditures.
Study Strengths and Limitations
The study presents a direct comparison of imaging modal-
ities in a primary study population sample of coronary
artery disease patients, for whom imaging was clinically
indicated. Only one study was obtained for each modal-
ity, so that re-test variability could not be tested. Similarly,
measurements were arrived at by consensus, so that inter
observer variability cannot be assessed. Other published
reports provide some information on these measures
[4,5,19]. Although slight differences in measurement
methodology (Simpson's vs. semi-Simpson's) could con-
tribute to results, study methods represent those most
commonly used and validated in practice for each modal-
ity. Also, given close intra-modality correlations between
these 2 methods, any differences due to measurement
methodology are likely to be very small. Contrast echocar-
diography and three dimensional (3-D) echocardiogra-
phy may provide more accurate LV volumetric and
functional measures than standard 2D echocardiography,
performed here, and may also correlate better with CMR
[4]. (It should be noted that 3-D CMR also is becoming
available and also may improve CMR slice selection.)
However, these techniques may add time and expense to
standard 2D techniques and are not fully incorporated
into routine clinical practice. The study is of only moder-
ate size and in a specific population, although size was
adequate to demonstrate systematic differences in the
studied metrics. Cost-effectiveness considerations also
must be considered in clinical practice but are not specifi-
cally addressed by this study. Finally, the reference control
group could be studied by CMR only.
Conclusion
In a moderately large CMR versus echocardiographic com-
parative study in post-MI patients in which each patient
served as his or her own control, metrics of LV volume and
function, while moderately correlated, showed significant
systematic inter modality differences, with echo underes-
timating all 5 primary measurement variables. CMR also
was more sensitive in distinguishing wall motion abnor-
malities. Of clinical importance, these differences by
modality suggest that serial measurements of function
should be performed using the same method. Given its
greater accuracy and reproducibility, CMR may be pre-
ferred when small to moderate serial changes in these
metrics are clinically important.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
BIG participated in study planning and design, performed
data analysis, and helped to draft the manuscript. SEB par-
ticipated in study planning and design, took part in data
acquisition, performed data analysis, and assisted with
manuscript revision. MRA took part in data acquisition,
performed data analysis, and assisted with manuscript
revision. DDB took part in data acquisition, performed
data analysis, and assisted with manuscript revision. JLA
participated in study planning and design, took part in
data acquisition, performed data analysis, helped to draft
the manuscript, and assisted with manuscript revision. All
authors read and approved the final manuscript.
Acknowledgements/Financial Support
This study was self-funded by the Departments of Cardiovascular Medicine, 
LDS Hospital, Intermountain Healthcare, Salt Lake City and Central Utah 
Clinic, Provo, Utah.
References
1. Manning WJ, Pennell DJ: Cardiovascular Magnetic Resonance New York:
Churchill Livingston; 2002. 
2. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU,
Pennell DJ: Comparison of interstudy reproducibility of cardi-
ovascular magnetic resonance with two-dimensional
echocardiography in normal subjects and in patients with
heart failure or left ventricular hypertrophy.  Am J Cardiol 2002,
90:29-34.
3. Pohost GM, Hung L, Doyle M: Clinical use of cardiovascular
magnetic resonance.  Circulation 2003, 108:647-653.
4. Jenkins C, Bricknell K, Chan J, Hanekom L, Marwick TH: Compari-
son of two- and three-dimensional echocardiography with
sequential magnetic resonance imaging for evaluating left
ventricular volume and ejection fraction over time in
patients with healed myocardial infarction.  Am J Cardiol 2007,
99:300-306.
5. Anderson JL, Weaver AN, Horne BD, Jones HU, Jelaco GK, Cha JA,
Busto HE, Hall J, Walker K, Blatter DD: Normal cardiac magnetic
resonance measurements and causes of interobserver dis-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Cardiovascular Ultrasound 2009, 7:38 http://www.cardiovascularultrasound.com/content/7/1/38
Page 7 of 7
(page number not for citation purposes)
crepancies in volumes and mass using the papillary muscle
inclusion method.  Open General and Internal Medicine Journal 2007,
1:6-12.
6. Gardin JM, Adams DB, Douglas PS, Feigenbaum H, Forst DH, Fraser
AG, Grayburn PA, Katz AS, Keller AM, Kerber RE, Khandheria BK,
Klein AL, Lang RM, Pierard LA, Quinones MA, Schnittger I, American
Society of Echocardiography: Recommendations for a standard-
ized report for adult transthoracic echocardiography: a
report from the American Society of Echocardiography's
Nomenclature and Standards Committee and Task Force
for a Standardized Echocardiography Report.  J Am Soc
Echocardiogr 2002, 15:275-290.
7. Feigenbaum H: Echocardiographic measurements and normal
values.  In Echocardiography 5th edition. Edited by: Feigenbaum H.
Philadelphia: Lea and Febiger; 1994:658-695. 
8. Reynolds T: 2-D numbers at a glance.  In Echocardiographer's
pocket reference Phoenix: Arizona Heart Institute Foundation. School
of Cardiac Ultrasound; 2000:166. 
9. Gerstenblith G, Frederiksen J, Yin FC, Fortuin NJ, Lakatta EG, Weis-
feldt ML: Echocardiographic assessment of a normal adult
aging population.  Circulation 1977, 56:273-278.
10. Cerqueira M: Standardized myocardial segmentation and
nomenclature for tomographic imaging of the heart: a state-
ment for healthcare professionals from the Cardiac Imaging
Committee of the Council on Clinical Cardiology of the
American Heart Association.  Circulation 2002, 105:539-542.
11. Bourdillon PD, Broderick TM, Sawada SG, Armstrong WF, Ryan T,
Dillon JC, Fineberg NS, Feigenbaum H: Regional wall motion
index for infarct and noninfarct regions after reperfusion in
acute myocardial infarction: comparison with global wall
motion index.  J Am Soc Echocardiogr 1989, 2:398-407.
12. Gordon EP, Schnittger I, Fitzgerald PJ, Williams P, Popp RL: Repro-
ducibility of left ventricular volumes by two-dimensional
echocardiography.  J Am Coll Cardiol 1983, 2:506-513.
13. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ,
Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul
WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM, Antman EM,
Smith SC Jr, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Hunt
SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO, American College
of Cardiology; American Heart Association; American Society of
Echocardiography: ACC/AHA/ASE 2003 guideline update for
the clinical application of echocardiography: summary arti-
cle: a report of the American College of Cardiology/Ameri-
can Heart Association Task Force on Practice Guidelines
(ACC/AHA/ASE Committee to Update the 1997 Guidelines
for the Clinical Application of Echocardiography).  Circulation
2003, 108:1146-1162.
14. Feigenbaum H, Armstrong WF, Ryan T: Feigenbaum's echocardiography
6th edition. Phildelphia: Lippinctoo Williams & Wilkins; 2005. 
15. Erbel R, Schweizer P, Herrn G, Mayer J, Effert S: Apical two-dimen-
sional echocardiography: normal values for single and bi-
plane determination of left ventricular volume and ejection
fraction.  Dtsch Med Wocheschr 1982, 107:1872-1877.
16. Reynolds T: The echocardiographer's pocket reference Phoenix: Arizona
Heart Institute; 2000. 
17. Maceira AM, Prasad SK, Khan M, Pennell DJ: Normalized left ven-
tricular systolic and diastolic function by steady state free
precession cardiovascular magnetic resonance.  J Cardiovasc
Magn Reson 2006, 8:417-426.
18. Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU:
Normal human left and right ventricular dimensions for MRI
as assessed by turbo gradient echo and steady-state free pre-
cession imaging sequences.  J Magn Reson Imaging 2003,
17:323-329.
19. Natori S, Lai S, Finn JP, Gomes AS, Hundley WG, Jerosch-Herold M,
Pearson G, Sinha S, Arai A, Lima JA, Bluemke DA: Cardiovascular
function in multi-ethnic study of atherosclerosis: normal val-
ues by age, sex, and ethnicity.  Am J Roentgenol 2006, 186(6
Suppl 2):S357-S365.
20. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP: Normal
human right and left ventricular mass, systolic function and
gender differences by cine magnetic resonance imaging.  J
Cardiovasc Magn Reson 1999, 1:7-21.
21. Anderson JL, Horne BD, Pennell DJ: Atrial Dimensions in Health
and Left Ventricular Disease Using Cardiovascular Magnetic
Resonance.  J Cardiovasc Magn Reson 2005, 7:671-675.